{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Abivax SA"},"Symbol":{"label":"Symbol","value":"ABVX"},"Address":{"label":"Address","value":"7 BD HAUSSMANN, PARIS, France"},"Phone":{"label":"Phone","value":"01 53 83 09 63"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.abivax.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Didier Scherrer","title":"Chief Scientific Officer"},{"name":"Fabio Cataldi","title":"Chief Medical Officer"},{"name":"Marc M. P. de Garidel","title":"Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}